Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$319.58 USD
+60.24 (23.23%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $318.00 -1.58 (-0.49%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/26/25 |
---|---|
Current Quarter | -5.93 |
EPS Last Quarter | -4.92 |
Last EPS Surprise | 29.11% |
ABR | 1.53 |
Earnings ESP
|
0.63% |
---|---|
Current Year | -27.27 |
Next Year | -17.72 |
EPS (TTM) | -25.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 52.97M | 74.67M | 100.90M | 368.08M |
# of Estimates | 7 | 3 | 7 | 7 |
High Estimate | 75.87M | 102.33M | 141.22M | 474.77M |
Low Estimate | 34.60M | 56.67M | 73.30M | 215.30M |
Year ago Sales | 0.00M | 0.00M | NA | 100.90M |
Year over Year Growth Est. | NA | NA | NA | 264.79% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -5.93 | -5.42 | -27.27 | -17.72 |
# of Estimates | 7 | 3 | 10 | 9 |
Most Recent Consensus | -6.22 | -4.37 | -26.42 | -11.47 |
High Estimate | -4.94 | -4.37 | -26.42 | -11.47 |
Low Estimate | -6.28 | -6.09 | -27.78 | -23.95 |
Year ago EPS | -5.68 | -7.38 | -19.99 | -27.27 |
Year over Year Growth Est. | -4.40% | 26.56% | -36.42% | 35.01% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 2 | 0 | 4 | 1 |
Up Last 60 Days | 2 | 0 | 4 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 2 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -5.93 | -5.42 | -27.27 | -17.72 |
7 Days Ago | -5.93 | -5.42 | -27.36 | -17.71 |
30 Days Ago | -7.94 | -5.42 | -29.49 | -17.76 |
60 Days Ago | -7.94 | -5.42 | -29.49 | -17.76 |
90 Days Ago | -5.69 | -5.65 | -27.70 | -17.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -5.89 | -5.42 | -27.03 | -18.96 |
Zacks Consensus Estimate | -5.93 | -5.42 | -27.27 | -17.72 |
Earnings ESP | 0.63% | 0.00% | 0.87% | -7.02% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -4.92 | -7.10 | -7.38 | -5.68 | NA |
Estimate | -6.94 | -7.55 | -6.06 | -5.32 | NA |
Difference | 2.02 | 0.45 | -1.32 | -0.36 | 0.20 |
Surprise | 29.11% | 5.96% | -21.78% | -6.77% | 1.63% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more